Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation

Table 3 Bivariate analysis of the relationship between continuous variables and troponin elevation

	Troponin elevation	n	Mean	SD	P value
Length of stay	0	1583	11.46	11.44	0.007
	1	205	14.16	13.52
Age	0	1583	66.14	16.49	0.08
	1	205	68.13	15.29
Body mass index	0	1540	30.11	8.62	0.64
	1	201	29.80	9.20
Oxygen on admission	0	1415	94.47	6.27	0.27
	1	187	94.20	6.69
C-reactive protein	0	1393	14.23	9.50	< 0.001
	1	182	17.47	9.70
Lactate dehydrogenase	0	1236	447.71	363.69	< 0.001
	1	148	819.34	1165.85
Ferritin	0	1099	956.44	1859.08	0.03
	1	141	1678.58	3844.02
Creatine phosphokinase	0	863	586.10	4245.13	0.01
	1	116	2014.03	5913.58
Platelet	0	1582	331.24	138.55	0.02
	1	204	307.00	138.15
WBC	0	1583	15.66	8.97	< 0.001
	1	204	19.76	8.88
Potassium	0	1341	4.78	0.83	< 0.001
	1	172	5.07	0.92
Total bilirubin	0	1577	0.95	0.83	0.004
	1	203	1.46	2.48

WBC: White blood cell.